Novorapid® Insulin Aspart U-100 Vials for Mealtime Control

What Novorapid® Is and How It Works

Novorapid® is insulin aspart, a rapid-acting mealtime insulin for adults and children with type 1 or type 2 diabetes. It comes as a 10 mL U-100 vial for use with insulin syringes or compatible pumps. Many people compare Novorapid Vial price and buy Novorapid Vial online to manage costs, including those purchasing Novorapid Vial without insurance.

YouDrugstore is a licensed Canadian pharmacy in Manitoba; licensed pharmacists review prescriptions before dispensing, we offer brand and generic medications at Canadian prices along with OTC health products, and you can order online or by phone with customer-service chat during posted hours.

We partner with licensed, vetted international pharmacies so you receive authentic brand medicines from a broad selection at affordable pricing.

Insulin aspart works by replacing your body’s missing insulin at meals. It starts to lower glucose about 10–20 minutes after injection, peaks around 1–3 hours, and lasts 3–5 hours. You use it before eating to cover carbohydrates and correct high readings as directed by your prescriber. Vials allow flexible dosing by syringe and are also used to fill pump reservoirs when appropriate.

Novorapid® is typically part of a basal–bolus plan, paired with a long-acting basal insulin. Your total daily dose and meal doses are individualized and may change with carbohydrate intake, activity, and glucose targets.

Dosage and Usage

• Confirm the vial is clear and colorless. Do not use if cloudy, colored, or contains particles.
• Use U-100 insulin syringes for accurate dosing. Do not share needles or syringes.
• Usual timing: inject within 5–10 minutes before a meal. Some plans allow dosing right after starting a meal.
• Dose is individualized. Providers may use carbohydrate ratios and correction factors to guide mealtime and correction doses.
• Missed dose: follow your care plan. If a meal was eaten, a rapid-acting correction may be used per instructions given by your prescriber.
• Injection sites: rotate within the abdomen, thigh, buttocks, or upper arm. Avoid injecting into areas that are tender, bruised, scarred, or lipodystrophic.
• Mixing: if your plan calls for mixing with NPH in a syringe, draw Novorapid® first and inject immediately. Do not mix with other insulins for pump use.
• Pump use: follow pump manufacturer instructions. Change infusion sets regularly and monitor glucose closely. Do not expose reservoirs or tubing to heat.

• Store unopened vials in a refrigerator at 2–8 °C (36–46 °F). Do not freeze. Keep away from the freezer compartment.
• After first use, you may store the vial at room temperature below 30 °C (86 °F) or refrigerated. Discard the opened vial 28 days after first puncture.
• Keep vials away from direct heat and light. Do not use if the insulin has been frozen or overheated.
• Travel: pack vials in an insulated bag with cool packs, not directly against ice. Carry a backup supply, syringes, and spare needles in your hand luggage.
• At airports, keep insulin with you. X-ray machines do not harm insulin. Bring a copy of your prescription and supplies in original packaging.
• For road trips, do not store insulin in a hot car or in the glove box. Use a travel cooler and check temperatures.

Benefits and Savings

Novorapid® offers fast onset and predictable action for mealtime control. It fits carbohydrate counting and correction dosing. The vial format supports precise dosing by syringe and can be used to fill pump reservoirs when appropriate. Many patients value its flexible timing around meals and reliable post-meal glucose reductions.

Ordering from Canada can lower costs significantly. Typical savings are 60–80% compared with many US pharmacy prices, especially for those paying without insurance. Multi-month supplies and bulk promotions can reduce the per-month cost and the number of shipments.

For current offers, see our Novorapid Vial coupon page.

Side Effects and Safety

• Low blood sugar (shakiness, sweating, fast heartbeat, headache, hunger, irritability)
• Injection site reactions (redness, itching, swelling)
• Lipodystrophy or skin thickening at injection sites
• Weight gain
• Mild edema
• Rash or itching
• Upper respiratory symptoms

Serious effects include severe hypoglycemia, severe allergic reactions, and hypokalemia. Risk of low blood sugar increases when Novorapid® is combined with other agents that lower glucose, especially sulfonylureas or basal insulin; dose adjustments may be needed. Thiazolidinediones used with insulin may cause fluid retention and heart failure. Discuss risks, sick-day plans, and driving or machinery precautions with your prescriber.

Onset Time

Novorapid® begins working about 10–20 minutes after injection, with most effect at 1–3 hours. Many people see improvements in post-meal readings within the first few days as doses are titrated. A1C changes are typically evaluated over 8–12 weeks. If starting pump therapy, stabilization may take several days while basal rates and meal boluses are refined.

Compare With Alternatives

Insulin lispro is another rapid-acting analog used at meals. It has a similar onset and duration, and many patients switch between them based on coverage, availability, or preference. If you are considering a switch, compare dosing guidance for the Humalog® Vial with your current plan.

Rapid-acting insulin is usually paired with a long-acting basal insulin for 24-hour background control. Glargine is a common option, dosed once daily. You can review basal options such as the Lantus® Vial when evaluating a full basal–bolus regimen with your provider.

Some patients use cartridges compatible with pen devices to simplify dosing. If you prefer prefilled systems, ask your prescriber which formats fit your dosing needs and devices.

Combination Therapy

• With basal insulin: a long-acting insulin provides background control; adjust mealtime doses to reduce hypoglycemia risk.
• With metformin: common in type 2 diabetes to reduce insulin needs.
• With GLP-1 receptor agonists: may lower post-meal excursions; mealtime insulin doses might be reduced.
• With SGLT2 inhibitors: monitor for dehydration and ketone risks; adjust insulin cautiously.
• With sulfonylureas: consider dose reductions to limit hypoglycemia.
• Pump therapy: use rapid-acting insulin only; do not mix with other insulins in the reservoir.

Patient Suitability and Cost-Saving Tips

Novorapid® is used for mealtime glucose control in people who need rapid-acting insulin. It is not for the treatment of diabetic ketoacidosis; emergency care and short-acting insulin infusions are used in that setting. Those with frequent severe hypoglycemia, significant kidney or liver disease, or insulin allergy require individualized plans and close supervision. Pregnancy and breastfeeding often require insulin adjustments and careful monitoring.

To lower costs, you can place a larger supply in one shipment when your prescriber authorizes it. Multi-month fills often bring a lower monthly price, and you can set simple reorder reminders so you do not run out. If you are comparing Novorapid insulin Vial cost without insurance, review total landed costs, including shipping, needles, and any pump supplies.

For quality assurance, order only from licensed pharmacies. Keep dosing records, check expiration dates, and rotate injection sites to protect skin health.

Authoritative Sources

NovoRapid (insulin aspart) information from Novo Nordisk Canada

Health Canada Drug Product Database entry for insulin aspart

FDA Prescribing Information for NovoLog (insulin aspart)

Order Novorapid® from Youdrugstore: add to cart, upload your prescription, and we ship with prompt, express, cold-chain handling.

This page is educational and does not replace professional medical advice. Always follow your prescriber’s instructions for dosing, monitoring, and changes to your treatment.